Diseases, Conditions, Syndromes

Dominant Alpha variant evolved to evade our innate immune system

The SARS-CoV-2 Alpha (B.1.1.7) variant mutated to evade our 'innate immune system', helping establish it as the world's first 'Variant of Concern', finds a new study led by researchers at UCL and the Quantitative Biosciences ...

Medications

A new medication uses protein against SARS-CoV-2

Vaccines against the SARS-CoV-2 virus have been made possible by an unprecedented worldwide collaboration. But medications against COVID-19 have as yet seen only partial success. With the support of the Bavarian Research ...

Diseases, Conditions, Syndromes

How SARS-CoV-2 evades the immune system

Researchers in Japan and the United States have found SARS-CoV-2 can knock out an important molecular pathway linked to an immune complex called MHC class I. The finding should help scientists better understand how COVID-19 ...

Diseases, Conditions, Syndromes

A chewing gum that could reduce SARS-CoV-2 transmission

A chewing gum laced with a plant-grown protein serves as a "trap" for the SARS-CoV-2 virus, reducing viral load in saliva and potentially tamping down transmission, according to a new study.

page 14 from 40